glp-1 doses Lower of the agonist medication as effective as higher ones, Danish study finds GLP-1 Dose Increase Guide: Titration

Here is how the two peptides match up across the goals we see most often

Prevalence and progression of NPS in AD patients Apathy, depression, anxiety, and agitation/aggression manifest early in AD, while hallucination and delusion generally occur at a later stage, often worsening as the disease progresses

No capsule product fixes the fundamental issue: human bioavailability data does not exist, so all systemic claims rest on animal injection studies

CagriSema (cagrilintide + semaglutide) was submitted to the FDA in late 2025 with a decision expected in 2026

Coroleuc CA, Coroleuc CB, Coroleuc R, Brtil PC, Nodii AR, Roca I, et al